Diagnostic tests often fail to lead to changes in patient outcomes.

[1]  P. Gøtzsche,et al.  Screening for breast cancer with mammography. , 2013, The Cochrane database of systematic reviews.

[2]  Mark P Purdue,et al.  Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. , 2012, The New England journal of medicine.

[3]  John P. A. Ioannidis,et al.  Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. , 2012, JAMA.

[4]  Anne Eisinga,et al.  A capture-recapture analysis demonstrated that randomized controlled trials evaluating the impact of diagnostic tests on patient outcomes are rare. , 2012, Journal of clinical epidemiology.

[5]  P. Bossuyt,et al.  Assessing the value of diagnostic tests: a framework for designing and evaluating trials , 2012, BMJ : British Medical Journal.

[6]  John P A Ioannidis,et al.  Reversals of established medical practices: evidence to abandon ship. , 2012, JAMA.

[7]  Vinay Prasad,et al.  The frequency of medical reversal. , 2011, Archives of internal medicine.

[8]  J. Thigpen Effect of Screening on Ovarian Cancer Mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial , 2011 .

[9]  A. Rosman,et al.  Effect of Verification Bias on the Sensitivity of Fecal Occult Blood Testing: a Meta-Analysis , 2010, Journal of General Internal Medicine.

[10]  Armando Santoro,et al.  A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. , 2009, American journal of respiratory and critical care medicine.

[11]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[12]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[13]  M. Lauer,et al.  Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. , 2009, Journal of cardiovascular computed tomography.

[14]  E. Barrett,et al.  Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. , 2009, JAMA.

[15]  J. Lijmer,et al.  Various randomized designs can be used to evaluate medical tests. , 2009, Journal of clinical epidemiology.

[16]  Rongwei Fu,et al.  Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[17]  J. Sch GRADE: grading quality of evidence and strength of recommendations for diagnostic tests and strategies , 2008, BMJ : British Medical Journal.

[18]  Gordon H Guyatt,et al.  GRADE: grading quality of evidence and strength of recommendations for diagnostic tests and strategies , 2008, BMJ : British Medical Journal.

[19]  Iztok Hozo,et al.  Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006. , 2008, Archives of internal medicine.

[20]  J. Neilson,et al.  Routine ultrasound in late pregnancy (after 24 weeks' gestation). , 2008, The Cochrane database of systematic reviews.

[21]  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.

[22]  D. Ramaekers,et al.  The evaluation of diagnostic tests: evidence on technical and diagnostic accuracy, impact on patient outcome and cost-effectiveness is needed. , 2007, Journal of clinical epidemiology.

[23]  J. Neilson,et al.  WITHDRAWN: Routine ultrasound in late pregnancy (after 24 weeks' gestation). , 2007, The Cochrane database of systematic reviews.

[24]  G. Leng,et al.  Screening for abdominal aortic aneurysm. , 2007, The Cochrane database of systematic reviews.

[25]  T. Wilt,et al.  Screening for prostate cancer. , 2013, The Cochrane database of systematic reviews.

[26]  C. Mancuso,et al.  Randomized controlled clinical trial of point-of-care, limited ultrasonography for trauma in the emergency department: the first sonography outcomes assessment program trial. , 2006, Annals of emergency medicine.

[27]  D. Grobbee,et al.  Distraction from randomization in diagnostic research. , 2006, Annals of epidemiology.

[28]  Sarah Lord,et al.  When Is Measuring Sensitivity and Specificity Sufficient To Evaluate a Diagnostic Test, and When Do We Need Randomized Trials? , 2006, Annals of Internal Medicine.

[29]  T. Wilt,et al.  Screening of prostate cancer. Is it needed? Russian experience , 2006 .

[30]  David J Samson,et al.  Challenges in Systematic Reviews of Diagnostic Technologies , 2005, Annals of Internal Medicine.

[31]  E. Chan Promoting an ethical approach to unproven screening imaging tests. , 2005, Journal of the American College of Radiology : JACR.

[32]  P. Rothwell,et al.  External validity of randomised controlled trials: “To whom do the results of this trial apply?” , 2005, The Lancet.

[33]  Konrad Jamrozik,et al.  Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm , 2004, BMJ : British Medical Journal.

[34]  P. Bossuyt,et al.  The diagnostic odds ratio: a single indicator of test performance. , 2003, Journal of clinical epidemiology.

[35]  G. Cable,et al.  Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma. , 2003, The Journal of the American Board of Family Practice.

[36]  A R Feinstein,et al.  Misguided efforts and future challenges for research on “diagnostic tests” , 2002, Journal of epidemiology and community health.

[37]  D. Sackett,et al.  The architecture of diagnostic research , 2002, BMJ : British Medical Journal.

[38]  Gabriel P Krestin,et al.  Study design for concurrent development, assessment, and implementation of new diagnostic imaging technology. , 2002, Radiology.

[39]  K. Maršál,et al.  Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial , 2001, The Lancet.

[40]  S. Chinn A simple method for converting an odds ratio to effect size for use in meta-analysis. , 2000, Statistics in medicine.

[41]  P. Bossuyt,et al.  Randomised comparisons of medical tests: sometimes invalid, not always efficient , 2000, The Lancet.

[42]  T. Merigan,et al.  A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy , 2000 .

[43]  P. Glasziou,et al.  Screening for colorectal cancer using the faecal occult blood test, hemoccult. , 2000, The Cochrane database of systematic reviews.

[44]  J. Neilson,et al.  Routine ultrasound in late pregnancy (after 24 weeks gestation). , 2000, The Cochrane database of systematic reviews.

[45]  J. Neilson,et al.  Ultrasound for fetal assessment in early pregnancy. , 2000, The Cochrane database of systematic reviews.

[46]  J. Lindholt,et al.  The validity of ultrasonographic scanning as screening method for abdominal aortic aneurysm. , 1999, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[47]  P. Glasziou,et al.  A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. , 1998, BMJ.

[48]  J. Ioannidis,et al.  Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.